AMNEAL PHARMACEUTICALS, INC. Deferred Income Tax Assets, Net
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Deferred Income Tax Assets, Net of $0 as of 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2020-03-02
- 2019-12-31: Deferred Income Tax Assets, Net $0.00.
- 2019-06-30: Deferred Income Tax Assets, Net $391.88M.
- 2019-03-31: Deferred Income Tax Assets, Net $382.94M.
- 2018-12-31: Deferred Income Tax Assets, Net $373.16M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-02 |
| 2019-06-30 | $391.88M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $382.94M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $373.16M 10-K · filed 2020-03-02 |
| 2018-09-30 | $365.97M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $373.70M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $898.00K 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |